Immunotherapy and Immune Checkpoints

Antibody therapies are the most successful immunotherapy, treating a wide range of cancers. Antibodies are proteins produced by the immune system that bind to a target antigen on the cell surface. In normal physiology the immune system uses them to fight pathogens. Each antibody is specific to one or a few proteins. Those that bind to cancer antigens are used to treat cancer. Cell surface receptors are common targets for antibody therapies. Among the most promising approaches to activating therapeutic antitumor immunity is the blockade of immune checkpoints. Immune checkpoints refer to a plethora of inhibitory pathways hardwired into the immune system that are crucial for maintaining self-tolerance and modulating the duration and amplitude of physiological immune responses in peripheral tissues in order to minimize collateral tissue damage. It is now clear that tumors co-opt certain immune-checkpoint pathways as a major mechanism of immune resistance, particularly against T cells that are specific for tumor antigens. Because many of the immune checkpoints are initiated by ligand–receptor interactions, they can be readily blocked by antibodies or modulated by recombinant forms of ligands or receptors. Cytotoxic T-lymphocyte-associated antigen 4 (CTLA4) antibodies were the first of this class of immunetherapeutics to achieve US Food and Drug Administration (FDA) approval.

  • Combinations of Check-Point Inhibitors
  • In Vivo Discovery of Immunotherapy Targets
  • Immune Suppression and Microenvironment
  • Sequencing or Combination Approaches in Immunotherapy
  • Chimeric Antigen Receptor Re-Directed T Cell Therapy

Related Conference of Immunotherapy and Immune Checkpoints

June 29-July 01, 2017

8th European Immunology Conference

Madrid, Spain
July 03-04, 2017

9thAnnual Meeting on Immunology and Immunologist

Kuala Lumpur, Malaysia
July 12-13, 2017

3rd World Conference on Parasitology & Pathogenesis

Chicago, Illinois, USA
August 07-08, 2017

Annual Summit on HIV/AIDS, STDs & STIs

Beijing, China
September 01-02, 2017

4th International Conference on Parasitology

Prague, Czech Republic
September 14-15, 2017

7th World Congress on Immunology

Amsterdam, Netherlands
September 21-22, 2017

International Conference on Parasitology and Infectious Diseases

San Antonio, Texas, USA
November 06-08, 2017

Infectious-disease- 2017 (CME & CPD Accredited)

Valencia, Spain
November 2-3, 2017

9th World Congress and Expo on Immunology

Atlanta, Georgia, USA
November 02-03, 2017

9th World Congress on Immunity, Inflammation and Immunotherapies

Atlanta, Georgia, USA
November 06-07, 2017

2nd International Conference on Autoimmunity

Frankfurt, Germany
November 08-09, 2017

3rd Antibodies and Bio Therapeutics Congress

Las Vegas, Nevada, USA
November 13-14, 2017

5th International Conference on HIV/AIDS, STDs and STIs

Las Vegas, Nevada, USA
December 04-06, 2017

Oncology- 2017 (CME & CPD Accredited)

London, UK
Dec 14-15, 2017

World Immunology Congress

Dubai, UAE

Immunotherapy and Immune Checkpoints Conference Speakers

Recommended Sessions

Related Journals

Are you interested in